Literature DB >> 8161539

Purification and characterization of bacterially expressed mammalian translation initiation factor 5 (eIF-5): demonstration that eIF-5 forms a specific complex with eIF-2.

J Chaudhuri1, K Das, U Maitra.   

Abstract

Eukaryotic translation initiation factor 5, eIF-5, has been purified to apparent electrophoretic homogeneity from overproducing Escherichia coli cells expressing the cDNA of the initiation factor under the control of the T7 promoter-T7 RNA polymerase system. Purified recombinant eIF-5 mimics natural eIF-5 isolated from mammalian cells in size, in specific activity, in its ability to catalyze the hydrolysis of GTP bound to the 40S initiation complex, and in the subsequent joining with 60S ribosomal subunits to form the 80S initiation complex. Further characterization of eIF-5 demonstrates that eIF-5 specifically associates with eIF-2, forming an eIF-2.eIF-5 complex. The protein complex sediments in glycerol gradients with an apparent M(r) of 160,000, suggesting that the two proteins associate in a 1:1 stoichiometry. The association between the two initiation factors is highly specific. Addition of 32P-labeled eIF-5 to a partially purified rabbit reticulocyte initiation factor preparation that contained, in addition to eIF-2 and eIF-5, other initiation factors and many other proteins resulted in the specific binding of labeled eIF-5 only to eIF-2, forming a 160-kDa protein complex. In agreement with these observations, we found that in crude initiation factor preparations derived from rabbit reticulocyte lysates, eIF-5 was present as an eIF-2.eIF-5 complex. The significance of eIF-2.eIF-5 complex formation in the overall mechanism of GTP hydrolysis in protein synthesis initiation is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8161539     DOI: 10.1021/bi00182a007

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Mutational analysis of mammalian translation initiation factor 5 (eIF5): role of interaction between the beta subunit of eIF2 and eIF5 in eIF5 function in vitro and in vivo.

Authors:  S Das; U Maitra
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Conserved bipartite motifs in yeast eIF5 and eIF2Bepsilon, GTPase-activating and GDP-GTP exchange factors in translation initiation, mediate binding to their common substrate eIF2.

Authors:  K Asano; T Krishnamoorthy; L Phan; G D Pavitt; A G Hinnebusch
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

3.  A multifactor complex of eukaryotic initiation factors, eIF1, eIF2, eIF3, eIF5, and initiator tRNA(Met) is an important translation initiation intermediate in vivo.

Authors:  K Asano; J Clayton; A Shalev; A G Hinnebusch
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

Review 4.  Protein-protein interactions required during translation.

Authors:  Daniel R Gallie
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

5.  Regulation of GTP hydrolysis prior to ribosomal AUG selection during eukaryotic translation initiation.

Authors:  Romit Majumdar; Umadas Maitra
Journal:  EMBO J       Date:  2005-10-13       Impact factor: 11.598

Review 6.  The plant translational apparatus.

Authors:  K S Browning
Journal:  Plant Mol Biol       Date:  1996-10       Impact factor: 4.076

7.  Phosphorylation of mammalian translation initiation factor 5 (eIF5) in vitro and in vivo.

Authors:  Romit Majumdar; Amitabha Bandyopadhyay; Haiteng Deng; Umadas Maitra
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

8.  The A1 x U72 base pair conserved in eukaryotic initiator tRNAs is important specifically for binding to the eukaryotic translation initiation factor eIF2.

Authors:  D Farruggio; J Chaudhuri; U Maitra; U L RajBhandary
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

9.  HCV and CSFV IRES domain II mediate eIF2 release during 80S ribosome assembly.

Authors:  Nicolas Locker; Laura E Easton; Peter J Lukavsky
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.